Kevin Kane
Founder & President

Kevin founded Phastar in 2007. He started his statistical career in 1990 with Amgen, moving to Wellcome after 3 years, and then stayed within the GSK family of companies over a number of years. Holding a variety of positions, including project statistician and technical support has given him a broad oversight of the clinical trial process, and he is still actively involved in providing statistical support. Kevin is a Chartered Statistician and a former Board Member for PSI (Statisticians in the Pharmaceutical Industry).

Graham Clark
Chief Executive Officer

Graham was recently appointed as Phastar's new Chief Executive Officer. Read the press release here.

Andrew MacGarvey
Chief Operating Officer

Andrew began his career in statistical programming over 25 years ago. He has held various technical roles in contract research organizations, served on several boards, and has worked in both the UK and the USA in leadership roles with a focus on growing businesses. Andrew is committed to delivering the best in customer service, creating an excellent working environment, and ensuring Phastar gives back to the wider community through initiatives such as Phastar CARES. Andrew holds a Law degree from the Open University and an MBA from Newcastle University.

Meirion Rees
Chief Financial Officer

Having held senior finance roles in a number of high growth businesses, Meirion specializes in supporting this growth with commercial insights to achieve strong topline momentum and drive profitability. Meirion is responsible for Phastar’s overall financial operations including IT and facilities. Meirion is a member of the Chartered Institute of Management Accountants and holds a BSc in Physics from Cardiff University.

Chuck Gelb
Chief Commercial Officer

With over 20 years’ experience across pharmaceutical companies and CROs, Chuck’s unique blend of experience provides critical insight into the needs of sponsors. Chuck brings the knowledge to build and manage a large, global sales and marketing team and provide liaison between board, operations, and sales. Chuck directs the commercial strategy in line with the company’s vision alongside driving the development of new talent within the organization and taking accountability for business targets and budgets. Chuck has an MBA in Pharmaceutical Management and an MA in Biotechnology.

Alastair Sword
Chief Business Officer

Alastair is a statistician with over 25 years of experience as both a manager and hands-on statistician across multiple therapeutic areas within the pharmaceutical industry and he brings expertise in managing groups that deliver projects to tight timelines. Responsible for the Operational Excellence team and the Quality Assurance function, Alastair matches the evolving business needs with updates to current processes and tools to deliver efficiencies and ensure quality. Alastair holds a BSc in Mathematics and MSc in Statistics.

Sheelagh Aird
Senior Director, Digital Health and Data Science

With more than 30 years of experience in clinical data management, Sheelagh has directed and delivered projects in all phases of clinical trials across numerous therapeutic areas and data collection platforms. Sheelagh holds a Doctorate in Pharmacokinetics from the University of Bath and BSc in Pharmacology from the University of Liverpool.

Peter Taylor
Senior Director, Global Head of Human Resources

With over 20 years of corporate HR experience, Peter has held senior roles at a number of global multinational corporations, in addition to HR consultant work supporting early start up biotech, gene therapy and small pharma companies. Peter holds a bachelor's degree from the University of Westminster and is a Fellow of the Chartered Institute of Personnel and Development.

Chris Brown
Senior Director and Global Head, Talent Acquisition

Chris is a dynamic global recruitment and operations leader with 23 years of experience in the Pharmaceutical and Healthcare sectors, and has spent 18 years as a biometrics hiring specialist. Chris's expertise covers staffing strategy, process improvement, post-merger recruitment integration, senior stakeholder management, geographic expansion, team management, and executive hiring.

Expert study design, statistical analysis, data science, data capture, and reporting for clinical trials